162 related articles for article (PubMed ID: 31155432)
1. Producing the 'problem' of new psychoactive substances (NPS) in English prisons.
Duke K
Int J Drug Policy; 2020 Jun; 80():102479. PubMed ID: 31155432
[TBL] [Abstract][Full Text] [Related]
2. 'Keeping a lid on it': Exploring 'problematisations' of prescribed medication in prisons in the UK.
Duke K; Trebilcock J
Int J Drug Policy; 2022 Feb; 100():103515. PubMed ID: 34798433
[TBL] [Abstract][Full Text] [Related]
3. Adding Spice to the Porridge: The development of a synthetic cannabinoid market in an English prison.
Ralphs R; Williams L; Askew R; Norton A
Int J Drug Policy; 2017 Feb; 40():57-69. PubMed ID: 27955961
[TBL] [Abstract][Full Text] [Related]
4. "A spray bottle and a lollipop stick": An examination of policy prohibiting sterile injecting equipment in prison and effects on young men with injecting drug use histories.
Walker S; Seear K; Higgs P; Stoové M; Wilson M
Int J Drug Policy; 2020 Jun; 80():102532. PubMed ID: 31427211
[TBL] [Abstract][Full Text] [Related]
5. Problematisation and centralised assessment in drug treatment sector reform.
Berends L
Int J Drug Policy; 2020 Jun; 80():102561. PubMed ID: 31611166
[TBL] [Abstract][Full Text] [Related]
6. The "problem" of health: An analysis of health care provision in Canada's federal prisons.
Scallan E; Lancaster K; Kouyoumdjian F
Health (London); 2021 Jan; 25(1):3-20. PubMed ID: 31055943
[TBL] [Abstract][Full Text] [Related]
7. Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985-2010.
Lancaster K; Ritter A
Int J Drug Policy; 2014 Jan; 25(1):81-7. PubMed ID: 23931957
[TBL] [Abstract][Full Text] [Related]
8. Responding to 'wicked problems': policy and governance on drug-related deaths in English and Welsh prisons, 2015-2021.
Duke K; MacGregor S
Int J Drug Policy; 2024 Apr; 126():104358. PubMed ID: 38401175
[TBL] [Abstract][Full Text] [Related]
9. New Psychoactive Substances and Violence within a UK Prison Setting.
Mason R; Smith M; Onwuegbusi T; Roberts A
Subst Use Misuse; 2022; 57(14):2146-2150. PubMed ID: 36269768
[No Abstract] [Full Text] [Related]
10. [Guidelines for substitution treatments in prison populations].
Michel L; Maguet O
Encephale; 2005; 31(1 Pt 1):92-7. PubMed ID: 15971645
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a framework for safe and appropriate prescribing of psychoactive medications in a UK prison.
Bebbington E; Lawson J; Nafees S; Robinson C; Poole R
Crim Behav Ment Health; 2021 Apr; 31(2):131-142. PubMed ID: 33306258
[TBL] [Abstract][Full Text] [Related]
12. New psychoactive substances, safety and mental health in prison officers.
Kinman G; Clements AJ
Occup Med (Lond); 2021 Nov; 71(8):346-350. PubMed ID: 34415337
[TBL] [Abstract][Full Text] [Related]
13. Analysis of drug-impregnated paper samples seized in English prisons between 2018 and 2020.
Akca AA; Couchman L; Frinculescu A; Johnston A
Forensic Sci Int; 2024 Apr; 357():111991. PubMed ID: 38513529
[TBL] [Abstract][Full Text] [Related]
14. Producing the vulnerable subject in English drug policy.
Brown K; Wincup E
Int J Drug Policy; 2020 Jun; 80():102525. PubMed ID: 31395470
[TBL] [Abstract][Full Text] [Related]
15. 'Potential issues of morbidity, toxicity and dependence': Problematizing the up-scheduling of over-the-counter codeine in Australia.
Weier M; Farrugia A
Int J Drug Policy; 2020 Jun; 80():102538. PubMed ID: 31362859
[TBL] [Abstract][Full Text] [Related]
16. New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances.
Chiappini S; Vaccaro G; Mosca A; Miuli A; Stigliano G; Stefanelli G; Giovannetti G; Carullo R; d'Andrea G; Di Carlo F; Cavallotto C; Pettorruso M; Di Petta G; Corkery JM; Guirguis A; Stair JL; Martinotti G; Fazel S; Schifano F
Neurosci Biobehav Rev; 2024 Jul; 162():105691. PubMed ID: 38733894
[TBL] [Abstract][Full Text] [Related]
17. The print media's construction of the 'drug problem' in Victorian newspapers: The case of North Richmond Community Health's medically supervised injecting room.
Whiteside B; Dunn M
Drug Alcohol Rev; 2022 May; 41(4):818-829. PubMed ID: 34674323
[TBL] [Abstract][Full Text] [Related]
18. Understanding the development of a regulated market approach to new psychoactive substances (NPS) in New Zealand using Punctuated Equilibrium Theory.
Rychert M; Wilkins C
Addiction; 2018 Nov; 113(11):2132-2139. PubMed ID: 29744945
[TBL] [Abstract][Full Text] [Related]
19. Exploring motivations to stop injecting in English prisons: qualitative research with former male prisoners.
Tompkins CN
Int J Prison Health; 2013; 9(2):68-81. PubMed ID: 25758439
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence and predictors of psychoactive substance use among men in prisons].
Caravaca-Sánchez F; Falcón Romero M; Luna A
Gac Sanit; 2015; 29(5):358-63. PubMed ID: 26228003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
